Nov. 30, 2023 — Slow waves that usually only occur in the brain during sleep are also present during wakefulness in people with epilepsy and may protect against increased brain excitability ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Qure's valuation appears slightly high relative to peers, with limited upside potential. Click here to learn why QURE stock ...

As most currently available treatments for epilepsy are symptom-based only, novel therapeutic strategies targeting underlying mechanisms of epileptogenesis and seizure-induced brain injury are needed.

In the latest in our series exploring some misconceptions about conditions seen in general practice, GP and paediatrics ...

A recent study published in the Journal of Affective Disorders reveals a potential link between the presence of antibodies for the parasite Toxoplasma gondii and an increased risk of developing ...

(Reuters) -H Lundbeck A/S has agreed to buy U.S.-based Longboard Pharmaceuticals for $2.6 billion, marking the biggest deal ...

The "Dravet Syndrome- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Dravet Syndrome- Pipeline Insight, 2024" report provides comprehensive insights ...

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion. Read more on ...

The number of children suffering from seizures after swallowing medications and illegal substances in the U.S. has doubled between 2009 and 2023, new research reveals. Over-the-counter ...

Unfortunately, there continues to be a very negative public view of ECT, partly due to its portrayal in the media.